A detailed history of Sarasin & Partners LLP transactions in Amgen Inc stock. As of the latest transaction made, Sarasin & Partners LLP holds 818,400 shares of AMGN stock, worth $216 Million. This represents 2.49% of its overall portfolio holdings.

Number of Shares
818,400
Previous 1,128,536 27.48%
Holding current value
$216 Million
Previous $353 Million 25.22%
% of portfolio
2.49%
Previous 3.12%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 09, 2024

SELL
$309.38 - $337.38 $95.9 Million - $105 Million
-310,136 Reduced 27.48%
818,400 $264 Million
Q2 2024

Jul 19, 2024

SELL
$262.75 - $319.31 $3.38 Million - $4.11 Million
-12,857 Reduced 1.13%
1,128,536 $353 Million
Q1 2024

Apr 12, 2024

SELL
$268.87 - $324.56 $1.69 Million - $2.04 Million
-6,300 Reduced 0.55%
1,141,393 $325 Million
Q4 2023

Jan 09, 2024

SELL
$255.7 - $288.46 $9.24 Million - $10.4 Million
-36,118 Reduced 3.05%
1,147,693 $331 Million
Q3 2023

Oct 05, 2023

SELL
$218.65 - $271.46 $13 Million - $16.1 Million
-59,287 Reduced 4.77%
1,183,811 $318 Million
Q2 2023

Jul 10, 2023

BUY
$214.27 - $253.37 $28.8 Million - $34 Million
134,366 Added 12.12%
1,243,098 $276 Million
Q1 2023

May 05, 2023

SELL
$225.79 - $275.2 $59.8 Million - $72.8 Million
-264,681 Reduced 19.27%
1,108,732 $268 Million
Q1 2023

Apr 27, 2023

BUY
$225.79 - $275.2 $91.5 Million - $112 Million
405,440 Added 41.89%
1,373,413 $332 Million
Q4 2022

Jan 30, 2023

SELL
$229.03 - $291.01 $5.68 Million - $7.21 Million
-24,789 Reduced 2.5%
967,973 $254 Million
Q3 2022

Oct 18, 2022

SELL
$224.46 - $253.15 $73.2 Million - $82.6 Million
-326,209 Reduced 24.73%
992,762 $224 Million
Q2 2022

Jul 13, 2022

SELL
$230.71 - $256.74 $10.3 Million - $11.5 Million
-44,636 Reduced 3.27%
1,318,971 $321 Million
Q1 2022

Apr 11, 2022

SELL
$219.27 - $242.57 $1.28 Million - $1.41 Million
-5,828 Reduced 0.43%
1,363,607 $330 Million
Q4 2021

Jan 19, 2022

BUY
$198.88 - $227.6 $32.9 Million - $37.7 Million
165,636 Added 13.76%
1,369,435 $308 Million
Q3 2021

Oct 22, 2021

BUY
$212.27 - $248.7 $8.6 Million - $10.1 Million
40,507 Added 3.48%
1,203,799 $256 Million
Q2 2021

Jul 13, 2021

BUY
$233.58 - $259.14 $15.1 Million - $16.7 Million
64,592 Added 5.88%
1,163,292 $284 Million
Q1 2021

Apr 29, 2021

BUY
$221.91 - $258.6 $9.63 Million - $11.2 Million
43,409 Added 4.11%
1,098,700 $273 Million
Q4 2020

Jan 19, 2021

BUY
$216.38 - $257.67 $21.6 Million - $25.8 Million
99,942 Added 10.46%
1,055,291 $243 Million
Q3 2020

Nov 09, 2020

SELL
$234.65 - $260.95 $2.54 Million - $2.82 Million
-10,816 Reduced 1.12%
955,349 $243 Million
Q2 2020

Jul 17, 2020

SELL
$197.81 - $242.74 $8.45 Million - $10.4 Million
-42,703 Reduced 4.23%
966,165 $228 Million
Q1 2020

Apr 30, 2020

SELL
$182.24 - $241.7 $12.2 Million - $16.2 Million
-67,122 Reduced 6.24%
1,008,868 $205 Million
Q4 2019

Feb 12, 2020

BUY
$189.21 - $243.2 $883,043 - $1.14 Million
4,667 Added 0.44%
1,075,990 $259 Million
Q3 2019

Nov 08, 2019

BUY
$174.11 - $208.62 $18.5 Million - $22.2 Million
106,302 Added 11.02%
1,071,323 $207 Million
Q2 2019

Jul 18, 2019

BUY
$166.7 - $195.41 $7.5 Million - $8.79 Million
44,977 Added 4.89%
965,021 $178 Million
Q1 2019

May 13, 2019

BUY
$180.87 - $203.88 $10.3 Million - $11.7 Million
57,152 Added 6.62%
920,044 $175 Million
Q4 2018

Feb 12, 2019

BUY
$178.4 - $208.25 $1.24 Million - $1.45 Million
6,960 Added 0.81%
862,892 $168 Million
Q3 2018

Nov 09, 2018

SELL
$185.29 - $208.89 $22.2 Million - $25.1 Million
-120,067 Reduced 12.3%
855,932 $177 Million
Q2 2018

Aug 07, 2018

BUY
$166.05 - $186.51 $1.27 Million - $1.43 Million
7,660 Added 0.79%
975,999 $180 Million
Q1 2018

May 01, 2018

BUY
$169.43 - $198.0 $8.37 Million - $9.79 Million
49,426 Added 5.38%
968,339 $165 Million
Q4 2017

Feb 06, 2018

SELL
$168.79 - $188.59 $1.03 Million - $1.15 Million
-6,104 Reduced 0.66%
918,913 $160 Million
Q3 2017

Nov 13, 2017

BUY
$167.29 - $191.0 $155 Million - $177 Million
925,017
925,017 $172 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $141B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Sarasin & Partners LLP Portfolio

Follow Sarasin & Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sarasin & Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Sarasin & Partners LLP with notifications on news.